You have 9 free searches left this month | for more free features.

Panitumumab

Showing 1 - 25 of 316

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Pancreatic Adenocarcinoma Trial in Palo Alto (procedure, biological, drug)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fluorescence Imaging
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)

Not yet recruiting
  • Brain Tumor
  • Stanford, California
    Stanford Cancer Center
Nov 9, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Pancreas Cancer Trial in Stanford (89Zr-panitumumab)

Suspended
  • Pancreas Cancer
  • Stanford, California
    Stanford University
Jun 15, 2022

Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)

Active, not recruiting
  • Lung Carcinoma
  • +4 more
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Head-and-neck Squamous Cell Carcinoma Trial in San Francisco (89Zr-panitumumab IV, Panitumumab)

Not yet recruiting
  • Head-and-neck Squamous Cell Carcinoma
  • 89Zr-panitumumab IV
  • Panitumumab
  • San Francisco, California
    Stanford Cancer Institute
Jun 14, 2022

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • Panitumumab
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Metastatic Colorectal Cancer Trial in Berlin (Panitumumab 20 milligram/ML, Bevacizumab, Trifluridine/Tipiracil Hydrochloride)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab 20 milligram/ML
  • +2 more
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Jul 20, 2022

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Panitumumab
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Head Neck Cancer Trial in Stanford (111I-n panitumumab, Single photon emission computed tomography/computed tomography

Recruiting
  • Head and Neck Cancer
  • 111I-n panitumumab
  • Single photon emission computed tomography/computed tomography (SPECT/CT) scans
  • Stanford, California
    Stanford University
Mar 11, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Metastatic Colorectal Cancer Trial in Mecca (Panitumumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab
  • Mecca, Makkah Western, Saudi Arabia
    King Abdullah Medical City, Holy Capital
Apr 5, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Head Neck Cancer Trial in Birmingham (Panitumumab-IRDye800)

Recruiting
  • Head and Neck Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 12, 2021

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

Metastatic Colorectal Cancer Trial in United States (panitumumab, Randomization to No Panitumumab)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • panitumumab
  • Randomization to No Panitumumab
  • Basking Ridge, New Jersey
  • +7 more
Apr 1, 2022

Advanced Head and Neck Squamous Cancer Trial (Panitumumab)

Completed
  • Advanced Head and Neck Squamous Cancer
  • Panitumumab
  • (no location specified)
Oct 19, 2021